在COVID-19期间患者的医疗保健利用率和死亡率:一项人口研究
Huw Strafford1, Joe Hollinghurst1, Arron S Lacey1
1Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK.
Epilepsia
|March 5, 2024
概括
在COVID-19大流行期间,患者 (PWE) 经历了医疗保健使用量减少,但相关死亡人数增加. 需要进一步研究PWE诊断和护理减少的长期影响.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 神经学 神经学
背景情况:
- COVID-19 流行病在全球范围内显著改变了医疗保健的获取和患者的治疗结果.
- 患有 (PWE) 的人可能会因潜在的护理中断和增加的脆弱性而受到不成比例的影响.
研究的目的:
- 调查COVID-19大流行期间与大流行前时期相比,PWE中医疗保健利用率和死亡率的变化.
- 分析新的诊断和状态率的趋势.
- 检查死亡模式,包括所有原因和相关的死亡.
主要方法:
- 对威尔士的匿名,人口规模的健康数据进行了回顾性分析.
- 在大流行前 (2016-2019) 和大流行 (2020-2021) 期间,PWE和没有的人 (PWOE) 的比较.
- 亚组分析包括儿童,老年人,智力障碍者和贫困地区的人. 用Poisson模型计算调整后的利率比率 (RRs).
主要成果:
- PWE的流行前医疗保健利用率高于PWOE. 在大流行期间,医院入院,急诊室和门诊病人的出院率显著下降PWE (RR范围:0.70-0.80).
- 在大流行期间,新的诊断下降 (RR=0.73). 全因死亡率没有显著增加,但与相关的非COVID死亡人数增加 (RR=1.29).
- 状态发症的发病率保持稳定 (RR=0.95). 在所有分析的子组中,观察到医疗保健利用率和新诊断的减少.
结论:
- 虽然非COVID全因死亡率没有上升,但与有关的非COVID死亡人数在流行病期间在PWE增加.
- 减少医疗保健利用率,减少新的诊断和增加相关死亡率的长期后果需要进一步调查.
更多相关视频
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
3.0K
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
25.6K
相关概念视频
Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
